摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4R,4aS,8R,8aR)-8-[(R)-1-(tert-Butyl-dimethyl-silanyloxymethyl)-2-methyl-propyl]-4-[(S)-2-(4-methoxy-benzyloxy)-1-methyl-ethyl]-6-methyl-3,4,4a,7,8,8a-hexahydro-1H-naphthalen-2-one | 583866-24-4

中文名称
——
中文别名
——
英文名称
(4R,4aS,8R,8aR)-8-[(R)-1-(tert-Butyl-dimethyl-silanyloxymethyl)-2-methyl-propyl]-4-[(S)-2-(4-methoxy-benzyloxy)-1-methyl-ethyl]-6-methyl-3,4,4a,7,8,8a-hexahydro-1H-naphthalen-2-one
英文别名
(4R,4aS,8R,8aR)-8-[(2R)-1-[tert-butyl(dimethyl)silyl]oxy-3-methylbutan-2-yl]-4-[(2S)-1-[(4-methoxyphenyl)methoxy]propan-2-yl]-6-methyl-3,4,4a,7,8,8a-hexahydro-1H-naphthalen-2-one
(4R,4aS,8R,8aR)-8-[(R)-1-(tert-Butyl-dimethyl-silanyloxymethyl)-2-methyl-propyl]-4-[(S)-2-(4-methoxy-benzyloxy)-1-methyl-ethyl]-6-methyl-3,4,4a,7,8,8a-hexahydro-1H-naphthalen-2-one化学式
CAS
583866-24-4
化学式
C33H54O4Si
mdl
——
分子量
542.875
InChiKey
VFLJUMPEDZAARH-MZMJYPAFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.32
  • 重原子数:
    38
  • 可旋转键数:
    12
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.73
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (4R,4aS,8R,8aR)-8-[(R)-1-(tert-Butyl-dimethyl-silanyloxymethyl)-2-methyl-propyl]-4-[(S)-2-(4-methoxy-benzyloxy)-1-methyl-ethyl]-6-methyl-3,4,4a,7,8,8a-hexahydro-1H-naphthalen-2-one咪唑盐酸草酰氯二甲基亚砜三乙胺三苯基膦2,3-二氯-5,6-二氰基-1,4-苯醌 作用下, 以 二氯甲烷丙酮 为溶剂, 反应 3.66h, 生成 (S)-2-[(1R,4aR,5R,8aS)-5-((R)-1-Iodomethyl-2-methyl-propyl)-7-methyl-3-oxo-1,2,3,4,4a,5,6,8a-octahydro-naphthalen-1-yl]-propionaldehyde
    参考文献:
    名称:
    Exploratory Studies Aimed at a Synthesis of Vinigrol. 3. Evaluation of a Lactone Bridge as a Conformational Lock
    摘要:
    DIAGRAMEvaluated in the present investigation are possible synthetic approaches to vinigrol based on the involvement of lactone rings as tools for the conformational rigidification of functionalized cis-octalins. Emphasis was placed on the structural arrangements resident in 3 and 5. The first of these systems proved to be highly strained and inaccessible. Especially notable was the finding that hydroxy ketenes 14 and 21 could be isolated and shown not to be amenable to cyclization when heated. The stereocontrolled assembly of 5 was successfully accomplished through exploitation of a related synthetic pathway. However, neither this attractive intermediate nor its close relative 33 could be processed in a manner that delivered the vinigrol framework. Nonetheless, several features of the routes deployed offer the prospect of wider application in other contexts.
    DOI:
    10.1021/jo0484575
  • 作为产物:
    描述:
    (1S,2S,4S,8R)-2-[(1E,3S)-4-(p-methoxybenzyloxy)-3-methyl-1-butenyl]-8-[(1R)-1-[(tert-butyldimethylsiloxy)methyl]-2-methylpropyl]-1-methylbicyclo[2.2.2]oct-5-en-2-ol 在 18-冠醚-6双(三甲基硅烷基)氨基钾 作用下, 以 四氢呋喃甲苯 为溶剂, 反应 1.0h, 以72%的产率得到(4R,4aS,8R,8aR)-8-[(R)-1-(tert-Butyl-dimethyl-silanyloxymethyl)-2-methyl-propyl]-4-[(S)-2-(4-methoxy-benzyloxy)-1-methyl-ethyl]-6-methyl-3,4,4a,7,8,8a-hexahydro-1H-naphthalen-2-one
    参考文献:
    名称:
    vinigrol的聚合对映选择性合成,这是一种结构新颖的二萜类化合物,具有有效的血小板聚集抑制和抗高血压特性。1.阴离子共生在辛基亚结构的构建中的应用。
    摘要:
    在0摄氏度存在MgBr(2).OEt(2)的情况下,构建基块15和36e的耦合以exo立体选择性(3.2:1)进行,比不使用碳氢化合物37e时更有利于获得甲醇37e。加性(exo / endo = 1:5.7)。设置顺式八氢萘55的所有相关立体中心的关键转换是37e的氧阴离子加速的[3,3]-σ重排。一个显着的特征是在结构上强制采用了船状过渡态,该态可用于以全顺式排列方式正确设置四个邻甲硫氨酸氢。由于最初通过埃文斯恶唑烷酮方案对映选择性地安装了异丙基取代基,因此55转化为碘砜62的方法可以通过X射线晶体学确认所有绝对立体化学赋值。没有观察到分子内阴离子环化62以产生三环骨架。这种反应性的缺乏归因于构象因素,该构象因素抑制了正确的S(N)2反应轨迹的实现。
    DOI:
    10.1021/jo0301301
点击查看最新优质反应信息

文献信息

  • Convergent Enantioselective Synthesis of Vinigrol, an Architecturally Novel Diterpenoid with Potent Platelet Aggregation Inhibitory and Antihypertensive Properties. 1. Application of Anionic Sigmatropy to Construction of the Octalin Substructure
    作者:Leo A. Paquette、Ronan Guevel、Shuichi Sakamoto、In Ho Kim、Jason Crawford
    DOI:10.1021/jo0301301
    日期:2003.8.1
    The coupling of building blocks 15 and 36e in the presence of MgBr(2).OEt(2) at 0 degrees C proceeds with an exo stereoselectivity (3.2:1) considerably more advantageous for the acquisition of carbinol 37e than in the absence of the additive (exo/endo = 1:5.7). The pivotal transformation that sets all of the relevant stereocenters of the cis-octalin 55 is the oxyanionic-accelerated [3,3]-sigmatropic
    在0摄氏度存在MgBr(2).OEt(2)的情况下,构建基块15和36e的耦合以exo立体选择性(3.2:1)进行,比不使用碳氢化合物37e时更有利于获得甲醇37e。加性(exo / endo = 1:5.7)。设置顺式八氢萘55的所有相关立体中心的关键转换是37e的氧阴离子加速的[3,3]-σ重排。一个显着的特征是在结构上强制采用了船状过渡态,该态可用于以全顺式排列方式正确设置四个邻甲硫氨酸氢。由于最初通过埃文斯恶唑烷酮方案对映选择性地安装了异丙基取代基,因此55转化为碘砜62的方法可以通过X射线晶体学确认所有绝对立体化学赋值。没有观察到分子内阴离子环化62以产生三环骨架。这种反应性的缺乏归因于构象因素,该构象因素抑制了正确的S(N)2反应轨迹的实现。
  • Exploratory Studies Aimed at a Synthesis of Vinigrol. 3. Evaluation of a Lactone Bridge as a Conformational Lock
    作者:Leo A. Paquette、Ivan Efremov
    DOI:10.1021/jo0484575
    日期:2005.1.1
    DIAGRAMEvaluated in the present investigation are possible synthetic approaches to vinigrol based on the involvement of lactone rings as tools for the conformational rigidification of functionalized cis-octalins. Emphasis was placed on the structural arrangements resident in 3 and 5. The first of these systems proved to be highly strained and inaccessible. Especially notable was the finding that hydroxy ketenes 14 and 21 could be isolated and shown not to be amenable to cyclization when heated. The stereocontrolled assembly of 5 was successfully accomplished through exploitation of a related synthetic pathway. However, neither this attractive intermediate nor its close relative 33 could be processed in a manner that delivered the vinigrol framework. Nonetheless, several features of the routes deployed offer the prospect of wider application in other contexts.
查看更多

同类化合物

(5β,6α,8α,10α,13α)-6-羟基-15-氧代黄-9(11),16-二烯-18-油酸 (3S,3aR,8aR)-3,8a-二羟基-5-异丙基-3,8-二甲基-2,3,3a,4,5,8a-六氢-1H-天青-6-酮 (2Z)-2-(羟甲基)丁-2-烯酸乙酯 (2S,4aR,6aR,7R,9S,10aS,10bR)-甲基9-(苯甲酰氧基)-2-(呋喃-3-基)-十二烷基-6a,10b-二甲基-4,10-dioxo-1H-苯并[f]异亚甲基-7-羧酸盐 (+)顺式,反式-脱落酸-d6 龙舌兰皂苷乙酯 龙脑香醇酮 龙脑烯醛 龙脑7-O-[Β-D-呋喃芹菜糖基-(1→6)]-Β-D-吡喃葡萄糖苷 龙牙楤木皂甙VII 龙吉甙元 齿孔醇 齐墩果醛 齐墩果酸苄酯 齐墩果酸甲酯 齐墩果酸乙酯 齐墩果酸3-O-alpha-L-吡喃鼠李糖基(1-3)-beta-D-吡喃木糖基(1-3)-alpha-L-吡喃鼠李糖基(1-2)-alpha-L-阿拉伯糖吡喃糖苷 齐墩果酸 beta-D-葡萄糖酯 齐墩果酸 beta-D-吡喃葡萄糖基酯 齐墩果酸 3-乙酸酯 齐墩果酸 3-O-beta-D-葡吡喃糖基 (1→2)-alpha-L-吡喃阿拉伯糖苷 齐墩果酸 齐墩果-12-烯-3b,6b-二醇 齐墩果-12-烯-3,24-二醇 齐墩果-12-烯-3,21,23-三醇,(3b,4b,21a)-(9CI) 齐墩果-12-烯-3,11-二酮 齐墩果-12-烯-2α,3β,28-三醇 齐墩果-12-烯-29-酸,3,22-二羟基-11-羰基-,g-内酯,(3b,20b,22b)- 齐墩果-12-烯-28-酸,3-[(6-脱氧-4-O-b-D-吡喃木糖基-a-L-吡喃鼠李糖基)氧代]-,(3b)-(9CI) 鼠特灵 鼠尾草酸醌 鼠尾草酸 鼠尾草酚酮 鼠尾草苦内脂 黑蚁素 黑蔓醇酯B 黑蔓醇酯A 黑蔓酮酯D 黑海常春藤皂苷A1 黑檀醇 黑果茜草萜 B 黑五味子酸 黏黴酮 黏帚霉酸 黄黄质 黄钟花醌 黄质醛 黄褐毛忍冬皂苷A 黄蝉花素 黄蝉花定